• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.

作者信息

Manca Davide, Cossu Giovanni, Murgia Daniela, Molari Andrea, Ferrigno Paola, Marcia Emanuele, Melis Maurizio

出版信息

Mov Disord. 2009 Nov 15;24(15):2293-4. doi: 10.1002/mds.22807.

DOI:10.1002/mds.22807
PMID:19795477
Abstract
摘要

相似文献

1
Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.帕金森病患者在使用多聚左旋多巴治疗期间出现的可逆性脑病和轴索性神经病。
Mov Disord. 2009 Nov 15;24(15):2293-4. doi: 10.1002/mds.22807.
2
Parkinson disease: adjunctive entacapone therapy increases risk of dyskinesia.帕金森病：辅助使用恩他卡朋治疗会增加运动障碍的风险。
Nat Rev Neurol. 2010 Nov;6(11):590-1. doi: 10.1038/nrneurol.2010.158.
3
Effect of levodopa and entacapone treatment on plasma homocysteine levels in Parkinson's disease patients.左旋多巴和恩他卡朋治疗对帕金森病患者血浆同型半胱氨酸水平的影响。
Parkinsonism Relat Disord. 2009 Jul;15(6):477-8. doi: 10.1016/j.parkreldis.2008.10.005. Epub 2008 Nov 22.
4
Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls.医院和护理机构中的帕金森病治疗：避免陷阱
Mayo Clin Proc. 2014 Jul;89(7):997-1003. doi: 10.1016/j.mayocp.2014.02.018.
5
Current pharmacotherapeutic treatment options in Parkinson's disease.帕金森病当前的药物治疗选择。
Dis Mon. 2007 Apr;53(4):214-22. doi: 10.1016/j.disamonth.2007.05.002.
6
Stalevo reduction in dyskinesia evaluation in Parkinson's disease results were expected from a pharmacokinetic viewpoint.从药代动力学角度来看，Stalevo在帕金森病异动症评估中的疗效是预期之中的。
Ann Neurol. 2011 Feb;69(2):424; author reply 425. doi: 10.1002/ana.22257.
7
Cardiovascular and mortality risks in Parkinson's disease patients treated with entacapone.恩他卡朋治疗帕金森病患者的心血管和死亡风险。
Mov Disord. 2013 Apr;28(4):490-7. doi: 10.1002/mds.25351. Epub 2013 Feb 26.
8
Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.早期帕金森病中应用和不应用恩他卡朋的左旋多巴/卡比多巴治疗：STRIDE-PD 研究。
Ann Neurol. 2010 Jul;68(1):18-27. doi: 10.1002/ana.22060.
9
Reply: neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.回复：帕金森病中左旋多巴使用的潜在并发症——神经病变：药理学与药物警戒视角
Mov Disord. 2010 Mar 15;25(4):525. doi: 10.1002/mds.22879.
10
Improving quality of life in early Parkinson's.改善早期帕金森病患者的生活质量。
Health News. 2005 Feb;11(2):2.

引用本文的文献

1
The vicious circle between homocysteine, methyl group-donating vitamins and chronic levodopa intake in Parkinson's disease.同型半胱氨酸、供甲基维生素与慢性左旋多巴摄入在帕金森病中的恶性循环。
J Neural Transm (Vienna). 2024 Jun;131(6):631-638. doi: 10.1007/s00702-023-02666-x. Epub 2023 Jun 17.
2
Prevalence and Risk Factors of Peripheral Neuropathy in Parkinson's Disease.帕金森病周围神经病变的患病率及危险因素
Ann Indian Acad Neurol. 2022 Nov-Dec;25(6):1109-1115. doi: 10.4103/aian.aian_669_22. Epub 2022 Dec 3.
3
Movement disorders and neuropathies: overlaps and mimics in clinical practice.
运动障碍和神经病变：临床实践中的重叠和模拟。
J Neurol. 2022 Sep;269(9):4646-4662. doi: 10.1007/s00415-022-11200-0. Epub 2022 Jun 3.
4
Large-Fiber Neuropathy in Parkinson's Disease: Clinical, Biological, and Electroneurographic Assessment of a Romanian Cohort.帕金森病中的大纤维神经病变：罗马尼亚队列的临床、生物学及神经电生理评估
J Clin Med. 2019 Sep 24;8(10):1533. doi: 10.3390/jcm8101533.
5
Myelinating Glia-Specific Deletion of Fbxo7 in Mice Triggers Axonal Degeneration in the Central Nervous System Together with Peripheral Neuropathy.在小鼠中髓鞘胶质细胞特异性敲除 Fbxo7 会引发中枢神经系统和周围神经病变中的轴突变性。
J Neurosci. 2019 Jul 10;39(28):5606-5626. doi: 10.1523/JNEUROSCI.3094-18.2019. Epub 2019 May 13.
6
Levodopa-Induced Neuropathy: A Systematic Review.左旋多巴诱发的神经病变：一项系统评价
Mov Disord Clin Pract. 2018 Nov 8;6(2):96-103. doi: 10.1002/mdc3.12688. eCollection 2019 Feb.
7
Infusion-rate-dependent Acute Neuropathic Pain with Duopa in a Patient with Parkinson's Disease and Pre-existing Neuropathy.帕金森病合并既往存在神经病变患者使用Duopa时出现的输注速率依赖性急性神经性疼痛
Cureus. 2018 Jul 26;10(7):e3055. doi: 10.7759/cureus.3055.
8
Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusion.左旋多巴-卡比多巴肠凝胶输注的长期安全性和有效性。
Brain Behav. 2017 Jul 7;7(8):e00758. doi: 10.1002/brb3.758. eCollection 2017 Aug.
9
Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion.接受左旋多巴-卡比多巴肠凝胶输注的患者的中枢传导异常。
Neurol Sci. 2017 Oct;38(10):1869-1872. doi: 10.1007/s10072-017-3029-z. Epub 2017 Jun 22.
10
Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience.左旋多巴-卡比多巴肠内悬浮液用于晚期帕金森病：临床证据与经验
Ther Adv Neurol Disord. 2017 Mar;10(3):171-187. doi: 10.1177/1756285616681280. Epub 2016 Dec 1.